J&J ce­ments foot­print in Italy with €580M in in­vest­ments over the next 5 years

John­son & John­son In­no­v­a­tive Med­i­cine (JJIM), for­mer­ly known as Janssen, is ear­mark­ing €580 mil­lion ($622 mil­lion) in in­vest­ments in Italy over the next five years …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.